194 related articles for article (PubMed ID: 19351819)
1. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.
Shih SC; Zukauskas A; Li D; Liu G; Ang LH; Nagy JA; Brown LF; Dvorak HF
Cancer Res; 2009 Apr; 69(8):3272-7. PubMed ID: 19351819
[TBL] [Abstract][Full Text] [Related]
2. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
[No Abstract] [Full Text] [Related]
3. TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration.
Zukauskas A; Merley A; Li D; Ang LH; Sciuto TE; Salman S; Dvorak AM; Dvorak HF; Jaminet SC
Angiogenesis; 2011 Sep; 14(3):345-54. PubMed ID: 21626280
[TBL] [Abstract][Full Text] [Related]
4. Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature.
Visintin A; Knowlton K; Tyminski E; Lin CI; Zheng X; Marquette K; Jain S; Tchistiakova L; Li D; O'Donnell CJ; Maderna A; Cao X; Dunn R; Snyder WB; Abraham AK; Leal M; Shetty S; Barry A; Zawel L; Coyle AJ; Dvorak HF; Jaminet SC
Mol Cancer Ther; 2015 Aug; 14(8):1868-76. PubMed ID: 26089370
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.
Park YR; Kim SL; Lee MR; Seo SY; Lee JH; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1915-1927. PubMed ID: 28528497
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
[TBL] [Abstract][Full Text] [Related]
7. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
8. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
[TBL] [Abstract][Full Text] [Related]
9. TM4SF1: a new vascular therapeutic target in cancer.
Lin CI; Merley A; Sciuto TE; Li D; Dvorak AM; Melero-Martin JM; Dvorak HF; Jaminet SC
Angiogenesis; 2014 Oct; 17(4):897-907. PubMed ID: 24986520
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
11. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
[TBL] [Abstract][Full Text] [Related]
12. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
13. TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells.
Huang YK; Fan XG; Qiu F
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153056
[TBL] [Abstract][Full Text] [Related]
14. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
15. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.
Zou X; Qiao H; Jiang X; Dong X; Jiang H; Sun X
J Biomed Sci; 2009; 16(1):33. PubMed ID: 19292890
[TBL] [Abstract][Full Text] [Related]
17. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.
Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M
Cancer Res; 2010 Feb; 70(4):1668-78. PubMed ID: 20124479
[TBL] [Abstract][Full Text] [Related]
18. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
[TBL] [Abstract][Full Text] [Related]
19. Quantitative gene-expression of the tumor angiogenesis markers vascular endothelial growth factor, integrin alphaV and integrin beta3 in human neuroendocrine tumors.
Oxboel J; Binderup T; Knigge U; Kjaer A
Oncol Rep; 2009 Mar; 21(3):769-75. PubMed ID: 19212638
[TBL] [Abstract][Full Text] [Related]
20. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM
Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
